BRIM (6885) reported revenue of NT$1.5 million for Oct 2026, +74.9% year on year and +19.6% from the previous month. Revenue for Jan–Oct 2026 was NT$11.4 million (+205.1% year on year).
Year-on-year revenue growth: 5 months in a row. →
In Oct 2026, it ranked No. 147 by revenue among 160 Biotech & Medical companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$1.5 million | +74.9% | +19.6% |
| Sep 2026 | NT$1.2 million | +209.5% | +11.7% |
| Aug 2026 | NT$1.1 million | +157.1% | +31.5% |
| Jul 2026 | NT$839,000 | +108.7% | -64.7% |
| Jun 2026 | NT$2.4 million | +491.5% | +189.3% |
| May 2026 | NT$822,000 | -27.9% | +7.3% |
| Apr 2026 | NT$766,000 | +2,152.9% | -36.4% |
| Mar 2026 | NT$1.2 million | +3,548.5% | +90.5% |
| Feb 2026 | NT$632,000 | +1,758.8% | -36.0% |
| Jan 2026 | NT$987,000 | +2,890.9% | -7.1% |
| Dec 2025 | NT$1.1 million | +3,121.2% | +56.6% |
| Nov 2025 | NT$679,000 | +237.8% | -19.5% |
| Oct 2025 | NT$843,000 | +2,454.5% | +111.8% |
| Sep 2025 | NT$398,000 | +1,106.1% | -7.2% |
| Aug 2025 | NT$429,000 | +1,200.0% | +6.7% |
| Jul 2025 | NT$402,000 | — | +0.0% |
| Jun 2025 | NT$402,000 | — | -64.7% |
| May 2025 | NT$1.1 million | — | +3,252.9% |
| Apr 2025 | NT$34,000 | — | +3.0% |
| Mar 2025 | NT$33,000 | — | -2.9% |
| Feb 2025 | NT$34,000 | — | +3.0% |
| Jan 2025 | NT$33,000 | — | +0.0% |
| Dec 2024 | NT$33,000 | -63.3% | -83.6% |
| Nov 2024 | NT$201,000 | — | +509.1% |
| Oct 2024 | NT$33,000 | — | +0.0% |
Jan–Oct 2026 cumulative: NT$11.4 million (+205.1% YoY)
Other Biotech & Medical companies
Compare with peers: BRIM vs PEC / BRIM vs Lotus Pharm / BRIM vs Bora
| Company | Revenue | YoY |
|---|---|---|
| PEC | NT$2.84 billion | +102.0% |
| Lotus Pharm | NT$2.13 billion | -22.5% |
| Bora | NT$1.99 billion | +15.9% |
| Great Tree Pharmacy | NT$1.67 billion | +1.5% |
| EXCELSIOR | NT$1.02 billion | +38.6% |
| PEGAVISION | NT$793 million | +13.0% |
| Synmosa Biopharma | NT$766.6 million | +41.2% |
| Y.S.H. | NT$749.4 million | +4.4% |
Company remark (original Chinese)
諮詢服務收入、含子公司營業收入
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16